These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28272074)

  • 41. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of persistent wide QRS in flecainide overdose with magnesium sulphate.
    Williamson DG; Sinha A; Frost I; Singh VK
    Emerg Med J; 2010 Jun; 27(6):487-8. PubMed ID: 20562156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Interactions of quinidine and propranolol with mexiletine, encainide, flecainide and tocainide].
    Halawa B
    Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):222-4. PubMed ID: 2120685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complete Heart Block Secondary to Flecainide Toxicity: Is It Time for CYP2D6 Genotype Testing?
    Poh BH; Lee JH; Abdul Haium AA; Choo TLJ
    Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32561613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Supraventricular tachyarrhythmias. Cardiac, extra-cardiac and arrhythmogenic side effects of anti-arrhythmia drugs].
    Meinertz T; Willems S; Weiss C
    Internist (Berl); 1998 Jan; 39(1):33-7. PubMed ID: 9530568
    [No Abstract]   [Full Text] [Related]  

  • 46. [Our experience with flecainide acetate in resistant arrhythmias in children. Apropos of 35 cases].
    Denjoy I; Lucet V; Do Ngoc D; Magnier S; Casasoprana A; Coumel P
    Arch Mal Coeur Vaiss; 1991 May; 84(5):647-52. PubMed ID: 1910326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth: a case report.
    Romeo E; D'Alto M; Russo MG; Sarubbi B; Cardaropoli D; Paladini D; Pacileo G; Annunziata A; Calabrò R
    Ital Heart J; 2004 Oct; 5(10):777-80. PubMed ID: 15626276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.
    Fish FA; Gillette PC; Benson DW
    J Am Coll Cardiol; 1991 Aug; 18(2):356-65. PubMed ID: 1906902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Supraventricular tachycardia resistant to treatment in a pregnant woman.
    Treakle K; Kostic B; Hulkower S
    J Fam Pract; 1992 Nov; 35(5):581-4. PubMed ID: 1431774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiarrhythmic treatment with flecainide (Tambocor). Clinical experience from 107 patients.
    Frandsen F; Pless P; Mickley H; Møller M
    Acta Cardiol; 1990; 45(5):351-7. PubMed ID: 1704167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Flecainide and anti-arrhythmia therapy].
    Croce L; Romano S; Pozzoni L; Lomuscio A
    Minerva Med; 1988 Mar; 79(3):229-34. PubMed ID: 3129677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment with flecainide for symptomatic and refractory tachyarrhythmias in children.
    Ismail Z; Alwi M; Lim MK; Murtazam HA; Jamaluddin A
    Acta Paediatr Jpn; 1994 Feb; 36(1):44-8. PubMed ID: 8165907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magnetocardiographic evaluation of nonarrhythmogenic flecainide-induced electrocardiographic T-wave inversion.
    Brisinda D; Sorbo AR; La Brocca L; Fenici R
    Anatol J Cardiol; 2017 Apr; 17(4):337-339. PubMed ID: 28466829
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of refractory supraventricular arrhythmias with flecainide acetate.
    Till JA; Rowland E; Shinebourne EA; Ward DE
    Arch Dis Child; 1987 Mar; 62(3):247-52. PubMed ID: 3105471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fatal flecainide intoxication.
    Brazil E; Bodiwala GG; Bouch DC
    J Accid Emerg Med; 1998 Nov; 15(6):423-5. PubMed ID: 9825278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
    Campbell JQ; Best TH; Eswaran H; Lowery CL
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH; Zabel M
    Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Flecaine: drug of choice for supraventricular tachycardias with anasarca. A case report].
    Hamel P; Febbraro W; Barjot P; Lindet Y; Muller G; Iselin M
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):37-9. PubMed ID: 9091542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term efficacy and safety of flecainide for supraventricular tachycardia.
    Neuss H; Schlepper M
    Am J Cardiol; 1988 Aug; 62(6):56D-61D. PubMed ID: 3136637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: a pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates.
    Damiano BP; van der Linde HJ; Van Deuren B; Somers Y; Lubomirski M; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2015; 72():72-84. PubMed ID: 25450838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.